Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by San Miguel JF

Collect these papers and discover other ones on Labmeeting. Learn more.

The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.

+ cite this

+ View Abstract

García-Sanz R, González-López TJ, Vázquez L, Hermida G, Graciani IF, and San Miguel JF

European journal of haematology 84(3):266-70, 2010 Mar 1 - Who cited this? | PubMed ID: 19912314 | Fulltext

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.

+ cite this

+ View Abstract

Gutiérrez NC, Sarasquete ME, Misiewicz-Krzeminska I, Delgado M, De Las Rivas J, Ticona FV, Fermiñán E, Martín-Jiménez P, Chillón C, Risueño A, Hernández JM, García-Sanz R, González M, and San Miguel JF

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 24(3):629-37, 2010 Mar - Who cited this? | PubMed ID: 20054351 | Fulltext

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.

+ cite this

+ View Abstract

Sánchez-Abarca LI, Gutierrez-Cosio S, Santamaría C, Caballero-Velazquez T, Blanco B, Herrero-Sánchez C, García JL, Carrancio S, Hernández-Campo P, González FJ, Flores T, Ciudad L, Ballestar E, Del Cañizo C, San Miguel JF, and Pérez-Simon JA

Blood 115(1):107-21, 2010 Jan 7 - Who cited this? | PubMed ID: 19887673 | Fulltext

The role of immature platelet fraction in acute coronary syndrome.

+ cite this

Gonzalez-Porras JR, Martin-Herrero F, Gonzalez-Lopez TJ, Olazabal J, Diez-Campelo M, Pabon P, Alberca I, and San Miguel JF

Thrombosis and haemostasis 103(1):247-9, 2010 Jan - Who cited this? | PubMed ID: 20062913 | Fulltext

Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.

+ cite this

+ View Abstract

Pérez-Persona E, Mateo G, García-Sanz R, Mateos MV, de Las Heras N, de Coca AG, Hernández JM, Galende J, Martín-Nuñez G, Bárez A, Alonso JM, Martín A, López-Berges C, Orfao A, San Miguel JF, and Vidriales MB

British journal of haematology 148(1):110-4, 2010 Jan - Who cited this? | PubMed ID: 19821821 | Fulltext

VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study.

+ cite this

+ View Abstract

Dimopoulos MA, Richardson PG, Schlag R, Khuageva NK, Shpilberg O, Kastritis E, Kropff M, Petrucci MT, Delforge M, Alexeeva J, Schots R, Masszi T, Mateos MV, Deraedt W, Liu K, Cakana A,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(36):6086-93, 2009 Dec 20 - Who cited this? | PubMed ID: 19858394 | Fulltext

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.

+ cite this

+ View Abstract

Santamaría CM, Chillón MC, García-Sanz R, Pérez C, Caballero MD, Ramos F, de Coca AG, Alonso JM, Giraldo P, Bernal T, Queizán JA, Rodriguez JN, Fernández-Abellán P, Bárez A, Peñarrubia MJ, Vidriales MB,

(show remaining authors)

Leukemia research 33(12):1706-9, 2009 Dec - Who cited this? | PubMed ID: 19457552 | Fulltext

Relapse/Refractory myeloma patient: potential treatment guidelines.

+ cite this

San Miguel JF

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(34):5676-7, 2009 Dec 1 - Who cited this? | PubMed ID: 19786652 | Fulltext

Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients.

+ cite this

+ View Abstract

Paiva B, Vidriales MB, Pérez JJ, Mateo G, Montalbán MA, Mateos MV, Bladé J, Lahuerta JJ, Orfao A, and San Miguel JF

Haematologica 94(11):1599-602, 2009 Nov - Who cited this? | PubMed ID: 19880781 | Fulltext

Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease.

+ cite this

+ View Abstract

Villanueva FN, Pérez-Simón JA, Silva FF, Caballero-Velázquez TT, Sánchez-Guijo FF, Cañizo CC, Vázquez LL, Caballero DD, and San Miguel JF

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 15(10):1331-6, 2009 Oct - Who cited this? | PubMed ID: 19747642 | Fulltext

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.

+ cite this

+ View Abstract

Sarasquete ME, González M, San Miguel JF, and García-Sanz R

Oral diseases 15(6):382-7, 2009 Sep - Who cited this? | PubMed ID: 19413677 | Fulltext

Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors.

+ cite this

+ View Abstract

Garayoa M, Garcia JL, Santamaria C, Garcia-Gomez A, Blanco JF, Pandiella A, Hernández JM, Sanchez-Guijo FM, del Cañizo MC, Gutiérrez NC, and San Miguel JF

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 23(8):1515-27, 2009 Aug - Who cited this? | PubMed ID: 19357701 | Fulltext

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia.

+ cite this

+ View Abstract

(show remaining authors)

Blood 114(1):148-52, 2009 Jul 2 - Who cited this? | PubMed ID: 19398719 | Fulltext

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population.

+ cite this

+ View Abstract

Blanco B, Pérez-Simón JA, Sánchez-Abarca LI, Caballero-Velazquez T, Gutierrez-Cossío S, Hernández-Campo P, Díez-Campelo M, Herrero-Sanchez C, Rodriguez-Serrano C, Santamaría C, Sánchez-Guijo FM, Del Cañizo C, and San Miguel JF

Haematologica 94(7):975-83, 2009 Jul - Who cited this? | PubMed ID: 19508976 | Fulltext

Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

+ cite this

+ View Abstract

Stadtmauer EA, Weber DM, Niesvizky R, Belch A, Prince MH, San Miguel JF, Facon T, Olesnyckyj M, Yu Z, Zeldis JB, Knight RD, and Dimopoulos MA

European journal of haematology 82(6):426-32, 2009 Jun - Who cited this? | PubMed ID: 19302559 | Fulltext

A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.

+ cite this

+ View Abstract

Hernández JA, Rodríguez AE, González M, Benito R, Fontanillo C, Sandoval V, Romero M, Martín-Núñez G, de Coca AG, Fisac R, Galende J, Recio I, Ortuño F, García JL, de Las Rivas J, Gutiérrez NC,

(show remaining authors)

Haematologica 94(3):364-71, 2009 Mar - Who cited this? | PubMed ID: 19252174 | Fulltext

Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease.

+ cite this

+ View Abstract

Perez-Andres M, Almeida J, Martin-Ayuso M, De Las Heras N, Moro MJ, Martin-Nuñez G, Galende J, Cuello R, Abuín I, Moreno I, Domínguez M, Hernandez J, Mateo G, San Miguel JF, and Orfao A

International journal of cancer. Journal international du cancer 124(2):367-75, 2009 Jan 15 - Who cited this? | PubMed ID: 19003959 | Fulltext

Prospective comparative analysis of the angiogenic capacity of monocytes and CD133+ cells in a murine model of hind limb ischemia.

+ cite this

+ View Abstract

López-Holgado N, Alberca M, Sánchez-Guijo FM, Villarón EM, Rivas JV, López-Novoa JM, Briñón JG, Arévalo MA, Oterino E, Santamaría C, San Miguel JF, and del Cañizo MC

Cytotherapy 11(8):1041-51, 2009 - Who cited this? | PubMed ID: 19929468 | Fulltext

Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.

+ cite this

+ View Abstract

Lahuerta JJ, Mateos MV, Martínez-López J, Rosiñol L, Sureda A, de la Rubia J, García-Laraña J, Martínez-Martínez R, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Ribera JM, Escoda L, Hernández-Ruiz B, García-Frade J,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(35):5775-82, 2008 Dec 10 - Who cited this? | PubMed ID: 19001321 | Fulltext

The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.

+ cite this

+ View Abstract

Santamaría C, Chillón MC, García-Sanz R, Balanzategui A, Sarasquete ME, Alcoceba M, Ramos F, Bernal T, Queizán JA, Peñarrubia MJ, Giraldo P, San Miguel JF, and Gonzalez M

Haematologica 93(12):1797-805, 2008 Dec - Who cited this? | PubMed ID: 18815192 | Fulltext

Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: efficacy and safety in patients with renal function impairment.

+ cite this

+ View Abstract

Bladé J, Sonneveld P, San Miguel JF, Sutherland HJ, Hajek R, Nagler A, Spencer A, Robak T, Cibeira MT, Zhuang SH, Harousseau JL, Orlowski RZ, and DOXIL-MMY-3001 Study Investigators

Clinical lymphoma & myeloma 8(6):352-5, 2008 Dec - Who cited this? | PubMed ID: 19064400 | Fulltext

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.

+ cite this

+ View Abstract

Paiva B, Vidriales MB, Cerveró J, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García de Coca A, de Las Heras N, Mateos MV, López-Berges MC, García-Boyero R, Galende J, Hernández J,

(show remaining authors)

Blood 112(10):4017-23, 2008 Nov 15 - Who cited this? | PubMed ID: 18669875 | Fulltext

Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study.

+ cite this

+ View Abstract

Lee SJ, Richardson PG, Sonneveld P, Schuster MW, Irwin D, San Miguel JF, Crawford B, Massaro J, Dhawan R, Gupta S, and Anderson KC

British journal of haematology 143(4):511-9, 2008 Nov - Who cited this? | PubMed ID: 18986387 | Fulltext

Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting.

+ cite this

+ View Abstract

Alcoceba M, Balanzategui A, Díez-Campelo M, Martín-Jiménez P, Sarasquete ME, Chillón MC, Santamaría C, Pérez-Simón JA, Marín L, Caballero MD, San Miguel JF, García-Sanz R, and González M

Transplantation 86(7):983-90, 2008 Oct 15 - Who cited this? | PubMed ID: 18852666 | Fulltext

Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.

+ cite this

+ View Abstract

Ayuk F, Perez-Simon JA, Shimoni A, Sureda A, Zabelina T, Schwerdtfeger R, Martino R, Sayer HG, Alegre A, Lahuerta JJ, Atanackovic D, Wolschke C, Nagler A, Zander AR, San Miguel JF, and Kröger N

Haematologica 93(9):1343-50, 2008 Sep - Who cited this? | PubMed ID: 18641030 | Fulltext

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

+ cite this

+ View Abstract

San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM, Schots R, Jiang B, Mateos MV, Anderson KC,

(show remaining authors)

The New England journal of medicine 359(9):906, 2008 Aug 28 - Who cited this? | PubMed ID: 18753647 | Fulltext

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.

+ cite this

+ View Abstract

Tabera S, Pérez-Simón JA, Díez-Campelo M, Sánchez-Abarca LI, Blanco B, López A, Benito A, Ocio E, Sánchez-Guijo FM, Cañizo C, and San Miguel JF

Haematologica, 2008 Jul 18 - Who cited this? | PubMed ID: 18641017 | Fulltext

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.

+ cite this

+ View Abstract

Sarasquete ME, Garcia-Sanz R, Marin L, Alcoceba M, Chillon MC, Balanzategui A, Santamaria C, Rosinol L, de la Rubia J, Hernandez MT, Garcia-Navarro I, Lahuerta JJ, Gonzalez M, and San Miguel JF

Blood, 2008 Jul 1 - Who cited this? | PubMed ID: 18594024 | Fulltext

Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.

+ cite this

+ View Abstract

Pérez-Simón JA, Martino R, Caballero D, Valcarcel D, Rebollo N, de la Cámara R, de Oteiza JP, Heras I, Calvo MV, Sierra J, San Miguel JF, and

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 14(6):664, 2008 Jun - Who cited this? | PubMed ID: 18489992 | Fulltext

Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.

+ cite this

+ View Abstract

Montero JC, López-Pérez R, San Miguel JF, and Pandiella A

Haematologica 93(6):851-9, 2008 Jun - Who cited this? | PubMed ID: 18443272 | Fulltext

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease.

+ cite this

+ View Abstract

Alcoceba M, Marín L, Balanzategui A, Sarasquete ME, Martín-Jiménez P, Chillón MC, Corral R, Pérez-Persona E, Fernández-Calvo FJ, Hernández JM, Bladé J, Lahuerta JJ, González M, San Miguel JF, and García-Sanz R

Tissue antigens 71(6):548-51, 2008 Jun - Who cited this? | PubMed ID: 18397187 | Fulltext

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy.

+ cite this

+ View Abstract

Mateo G, Montalbán MA, Vidriales MB, Lahuerta JJ, Mateos MV, Gutiérrez N, Rosiñol L, Montejano L, Bladé J, Martínez R, de la Rubia J, Diaz-Mediavilla J, Sureda A, Ribera JM, Ojanguren JM, de Arriba F,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(16):2737-44, 2008 Jun 1 - Who cited this? | PubMed ID: 18443352 | Fulltext

Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification.

+ cite this

+ View Abstract

Carrancio S, López-Holgado N, Sánchez-Guijo FM, Villarón E, Barbado V, Tabera S, Díez-Campelo M, Blanco J, San Miguel JF, and Del Cañizo MC

Experimental hematology, 2008 May 9 - Who cited this? | PubMed ID: 18468767 | Fulltext

The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.

+ cite this

+ View Abstract

Maiso P, Ocio EM, Garayoa M, Montero JC, Hofmann F, García-Echeverría C, Zimmermann J, Pandiella A, and San Miguel JF

British journal of haematology 141(4):470-82, 2008 May - Who cited this? | PubMed ID: 18341634 | Fulltext

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.

+ cite this

+ View Abstract

Mateos MV, Hernández JM, Hernández MT, Gutiérrez NC, Palomera L, Fuertes M, Garcia-Sanchez P, Lahuerta JJ, de la Rubia J, Terol MJ, Sureda A, Bargay J, Ribas P, Alegre A, de Arriba F, Oriol A,

(show remaining authors)

Haematologica 93(4):560, 2008 Apr - Who cited this? | PubMed ID: 18322252 | Fulltext

Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma.

+ cite this

+ View Abstract

Armellini A, Sarasquete ME, García-Sanz R, Chillón MC, Balanzategui A, Alcoceba M, Fuertes M, López R, Hernández JM, Fernández-Calvo J, Sierra M, Megido M, Orfão A, Gutiérrez NC, González M, and San Miguel JF

British journal of haematology 141(2):212-5, 2008 Apr - Who cited this? | PubMed ID: 18353163 | Fulltext

Recent Phase III Trials in the Frontline Treatment of Multiple Myeloma: Evaluating Their Impact on Community Practice.

+ cite this

+ View Abstract

San Miguel JF, Facon T, and Cavo M

Clinical advances in hematology & oncology : H&O 6(4 Suppl 10):1-12, 2008 Apr - Who cited this? | PubMed ID: 18496501 | Fulltext

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.

+ cite this

+ View Abstract

Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H, Dalva K, Fuhler G, Gratama J, Hose D, Kovarova L, Lioznov M, Mateo G, Morilla R, Mylin AK, Omedé P,

(show remaining authors)

Haematologica 93(3):431, 2008 Mar - Who cited this? | PubMed ID: 18268286 | Fulltext

The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.

+ cite this

+ View Abstract

Colado E, Alvarez-Fernández S, Maiso P, Martín-Sánchez J, Vidriales MB, Garayoa M, Ocio EM, Montero JC, Pandiella A, and San Miguel JF

Haematologica 93(1):57, 2008 Jan - Who cited this? | PubMed ID: 18166786 | Fulltext

Peripheral blood dendritic cell subsets from patients with monoclonal gammopathies show an abnormal distribution and are functionally impaired.

+ cite this

+ View Abstract

Martín-Ayuso M, Almeida J, Pérez-Andrés M, Cuello R, Galende J, González-Fraile MI, Martín-Nuñez G, Ortega F, Rodríguez MJ, San Miguel JF, and Orfao A

The oncologist 13(1):82, 2008 Jan - Who cited this? | PubMed ID: 18245015 | Fulltext

Bortezomib in multiple myeloma.

+ cite this

+ View Abstract

Mateos MV and San Miguel JF

Best practice & research. Clinical haematology 20(4):701-15, 2007 Dec - Who cited this? | PubMed ID: 18070714 | Fulltext

Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.

+ cite this

+ View Abstract

González D, van der Burg M, García-Sanz R, Fenton JA, Langerak AW, González M, van Dongen JJ, San Miguel JF, and Morgan GJ

Blood 110(9):3112, 2007 Nov 1 - Who cited this? | PubMed ID: 17634408 | Fulltext

Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia.

+ cite this

+ View Abstract

Martín-Jiménez P, García-Sanz R, González D, Balanzategui A, Pérez JJ, Caballero MD, Sarasquete ME, Galende J, Orfao A, López-Berges MC, San Miguel JF, and González M

Clinical lymphoma & myeloma 7(9):573-9, 2007 Nov - Who cited this? | PubMed ID: 18186965 | Fulltext

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.

+ cite this

+ View Abstract

Pérez-Persona E, Vidriales MB, Mateo G, García-Sanz R, Mateos MV, de Coca AG, Galende J, Martín-Nuñez G, Alonso JM, de Las Heras N, Hernández JM, Martín A, López-Berges C, Orfao A, and San Miguel JF

Blood 110(7):2586-92, 2007 Oct 1 - Who cited this? | PubMed ID: 17576818 | Fulltext

Molecular biology of myeloma.

+ cite this

+ View Abstract

Gutiérrez NC, García-Sanz R, and San Miguel JF

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 9(10):618-24, 2007 Oct - Who cited this? | PubMed ID: 17974522 | Fulltext

In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.

+ cite this

+ View Abstract

Villaron EM, Almeida J, Lopez-Holgado N, Sanchez-Guijo FM, Alberca M, Blanco B, Sanchez-Abarca LI, Lopez O, Perez-Simon JA, San Miguel JF, and Del Cañizo MC

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 37(2):145-56, 2007 Oct - Who cited this? | PubMed ID: 17983836 | Fulltext

Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation.

+ cite this

+ View Abstract

Mateos-Mazon J, Pérez-Simón JA, Lopez O, Hernández E, Etxebarria J, and San Miguel JF

Haematologica 92(9):1295-6, 2007 Sep - Who cited this? | PubMed ID: 17768136 | Fulltext

Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.

+ cite this

Bagán J, Blade J, Cozar JM, Constela M, García Sanz R, Gómez Veiga F, Lahuerta JJ, Lluch A, Massuti B, Morote J, San Miguel JF, and Solsona E

Medicina oral, patologia oral y cirugia bucal 12(4):E336-40, 2007 Jul - Who cited this? | PubMed ID: 17664922 | Fulltext

[Multiple myeloma].

+ cite this

+ View Abstract

García-Sanz R, Mateos MV, and San Miguel JF

Medicina clinica 129(3):104-15, 2007 Jun 16 - Who cited this? | PubMed ID: 17594862 | Fulltext

Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.

+ cite this

+ View Abstract

Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, San Miguel JF, Cavenagh JD, and Anderson KC

British journal of haematology 137(5):429-35, 2007 Jun - Who cited this? | PubMed ID: 17451408 | Fulltext

Search Google Scholar for San Miguel JF

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.